Chemical Market Reporter - Sanofi's Eloxatin gains FDA approval. (Market: Life
Posted on Monday, August 19 @ 07:00:00 CDT by admin
August 19, 2002 -- SANOFI-SYNTHELABO has pulled a stroke ahead of troubled ImClone Systems Inc. in the race for the US colorectal cancer market. Last week the Food ...
Click Here to read the entire article...
|
| |
|